PHIN:NYSEPHINIA Inc. Analysis
Data as of 2026-06-13 - not real-time
$85.16
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
PHINIA Inc. is trading at $85.16, just below its DCF‑derived fair value of $85.60 and enjoys an 8% upside potential based on the model. The stock sits comfortably above its 20‑day SMA ($78.06) and 50‑day SMA ($75.48), while the 200‑day SMA ($65.19) remains well under the current price, underscoring a strong long‑term bullish bias. Technical momentum is reinforced by a bullish MACD histogram (+0.46) and a solid RSI of 67, indicating continued buying pressure without being overbought. Volume is on an increasing trend, supporting the price advance toward the resistance level of $86.64. Fundamentals show a respectable forward PE of 12.6 versus a trailing PE of 23.9, a healthy dividend yield of 1.41% with a modest payout ratio of 31%, and a solid free cash flow generation of $190 M. Revenue growth of 10% and a forward EPS outlook of $6.74 suggest earnings momentum, while the debt‑to‑equity of 67% is manageable given the $328 M cash balance. The sector’s consumer‑cyclical nature adds cyclical exposure, but the company’s diversified fuel‑system and aftermarket portfolio mitigates concentration risk. Overall, the confluence of bullish technicals, attractive valuation, and sustainable dividend makes PHIN a compelling near‑term play.
However, the 30‑day volatility of 36.7% and a beta of 1.16 signal heightened price swings, warranting disciplined position sizing. Investors should monitor the $86.64 resistance and upcoming earnings guidance to confirm the upside trajectory.
However, the 30‑day volatility of 36.7% and a beta of 1.16 signal heightened price swings, warranting disciplined position sizing. Investors should monitor the $86.64 resistance and upcoming earnings guidance to confirm the upside trajectory.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD and RSI indicating strong momentum
- Current price below DCF fair value with 8% upside
- Increasing volume supporting price rise
Medium Term
1–3 yearsNeutral
Model confidence: 8/10
Key Factors
- Forward earnings growth and improving forward PE
- Sustainable dividend payout and cash flow coverage
- Potential resistance at $86.64 could cap short‑term gains
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑term trend above all major SMAs
- Diversified product mix reducing cyclicality
- Undervalued relative to DCF and attractive dividend yield
Key Metrics & Analysis
Financial Health
Revenue Growth10.30%
Profit Margin3.96%
P/E Ratio23.9
ROE9.14%
ROA5.43%
Debt/Equity67.08
P/B Ratio2.0
Op. Cash Flow$325.0M
Free Cash Flow$189.8M
Technical Analysis
TrendBullish
RSI67.2
Support$71.21
Resistance$86.64
MA 20$78.06
MA 50$75.48
MA 200$65.19
MACDBullish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair Value$85.60
Target Price$92.00
Upside/Downside8.03%
GradeUndervalued
TypeBlend
Dividend Yield1.41%
Risk Assessment
Beta1.16
Volatility36.74%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.